A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma

BACKGROUND: Design and execution of immunotherapy trials for seasonal allergies may be complicated by numerous factors including variable allergy testing methods, pollen levels, and timing and intensity of other seasonal allergens. We evaluated grass allergy immunotherapy tablet (AIT) treatment in N...

Descripción completa

Detalles Bibliográficos
Autores principales: Murphy, Kevin, Gawchik, Sandra, Bernstein, David, Andersen, Jens, Pedersen, Martin Rud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3689082/
https://www.ncbi.nlm.nih.gov/pubmed/23725348
http://dx.doi.org/10.1186/1477-5751-12-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3689082/
https://www.ncbi.nlm.nih.gov/pubmed/23725348
http://dx.doi.org/10.1186/1477-5751-12-10

Ejemplares similares